Iranian Society of Gynecology Oncology

Document Type : Case Report Article

Authors

1 Department of Radiology Oncology, Iran University of Medical Sciences, Tehran, Iran

2 Department of Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Non-Hodgkin lymphomas are a heterogeneous group of lymphoproliferative disorders with various behaviors and responses to treatment. As a primary extranodal NHL, the disease must be confined to one location, and bone marrow should not be involved. Primary uterine cervix lymphoma is a rare malignancy as well as a rare site of extranodal lymphoma. Because of the rarity of the disease, there is no standard treatment guideline for women with primary uterine cervix lymphoma. Patients mostly present with abnormal uterine bleeding, vaginal discharge or pelvic pain. Typically, a pap smear may not show the malignant cells in the specimen. When the diagnosis is made, management may be debated due to its rarity and lack of standard treatment. Surgery, chemotherapy, chemo-immunotherapy and radiotherapy, either alone or in combination, are the treatment options.  Most patients respond well to chemotherapy and radiation therapy. The prognosis is usually favorable. Here, we report a case of primary cervical lymphoma in a 50-year-old woman who presented with abnormal vaginal bleeding. She was treated with radiotherapy and chemo-immunotherapy and remained disease-free after nine months of treatment.

Highlights

 Non-Hodgkin lymphomas are a heterogeneous group of lymphoproliferative disorders with various behaviors and responses to treatment. As a primary extranodal NHL, the disease must be confined to one location, and bone marrow should not be involved.

Keywords

Main Subjects

1. Coiffier B, Lepage E, Brière J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. New Eng J Med. 2002;346(4):235-42. [DOI:10.1056/NEJMoa011795] [PMID]
2. Nasioudis D, Kampaktsis PN, Frey M, Witkin SS, Holcomb K. Primary lymphoma of the female genital tract: An analysis of 697 cases. Gynecol Oncol. 2017;145(2):305-9. [DOI:10.1016/j.ygyno.2017.02.043] [PMID]
3. Solone M, Hillard P. Adult gynecology: reproductive year. Berek & Novak's gynecology. Philadelphia Lippincott Williams & Wilkins; 2020. p. 193-222.
4. Mandato VD, Palermo R, Falbo A, Capodanno I, Capodanno F, Gelli MC, et al. Primary diffuse large B-cell lymphoma of the uterus: case report and review. Anticancer Res. 2014;34(8):4377-90.
5. Garavaglia E, Taccagni G, Montoli S, Panacci N, Ponzoni M, Frigerio L, et al. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients. Gynecol Oncol. 2005;97(1):214-8. [DOI:10.1016/j.ygyno.2004.07.065] [PMID]
6. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines) with NCCN Evidence Blocks: B-cell lymphomas: version 3.2022 [Internet]: Plymouth Meeting (PA): National Comprehensive Cancer Network; 2022.
7. Slonimsky E, Korach J, Perri T, Davidson T, Apter S, Inbar Y. Gynecological Lymphoma: A Case Series and Review of the Literature. J Comput Assist Tomogr. 2018;42(3):435-40. [DOI:10.1097/RCT.0000000000000709] [PMID]
8. Thyagarajan MS, Dobson MJ, Biswas A. Case report: appearance of uterine cervical lymphoma on MRI: a case report and review of the literature. Br J Radiol. 2004;77(918):512-5. [DOI:10.1259/bjr/58044417] [PMID]
9. Saneii M, Fadavi P, Novin K, Garousi M. Metachronous Diffuse Large B-Cell Lymphoma of the Breasts: A Case Report and Review of the Literature. Int J Cancer Manag. 2021;14(6):e114180. [DOI:10.5812/ijcm.114180]
10. Cristina C, Laura AC, Sabina AA, Eugen B, Laurentiu S, Virgiliu-Mihail P. Primary Non-Hodgkin Uterine Lymphoma of the Cervix: A Literature Review. Medicina. 2022;58(1):106. [DOI:10.3390/medicina58010106] [PMID] [PMCID]